Farallon Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-2,341,424
| Closed | -$149M | – | 153 |
|
2025
Q1 | $149M | Sell |
2,341,424
-523,676
| -18% | -$33.4M | 0.74% | 38 |
|
2024
Q4 | $348M | Buy |
2,865,100
+285,100
| +11% | +$34.7M | 1.56% | 22 |
|
2024
Q3 | $322M | Buy |
2,580,000
+285,000
| +12% | +$35.6M | 1.42% | 23 |
|
2024
Q2 | $363M | Sell |
2,295,000
-158,500
| -6% | -$25M | 1.56% | 17 |
|
2024
Q1 | $318M | Buy |
2,453,500
+1,243,427
| +103% | +$161M | 1.35% | 19 |
|
2023
Q4 | $117M | Sell |
1,210,073
-165,127
| -12% | -$15.9M | 0.54% | 41 |
|
2023
Q3 | $167M | Buy |
1,375,200
+170,000
| +14% | +$20.6M | 0.78% | 35 |
|
2023
Q2 | $138M | Buy |
1,205,200
+291,900
| +32% | +$33.4M | 0.69% | 37 |
|
2023
Q1 | $126M | Sell |
913,300
-15,600
| -2% | -$2.15M | 0.69% | 41 |
|
2022
Q4 | $120M | Buy |
928,900
+173,950
| +23% | +$22.5M | 0.71% | 42 |
|
2022
Q3 | $83.5M | Sell |
754,950
-430,101
| -36% | -$47.5M | 0.46% | 55 |
|
2022
Q2 | $88.8M | Buy |
1,185,051
+193,076
| +19% | +$14.5M | 0.48% | 55 |
|
2022
Q1 | $77.5M | Buy |
991,975
+152,966
| +18% | +$11.9M | 0.37% | 55 |
|
2021
Q4 | $75.6M | Buy |
839,009
+677,009
| +418% | +$61M | 0.38% | 51 |
|
2021
Q3 | $15M | Buy |
+162,000
| New | +$15M | 0.07% | 114 |
|
2021
Q2 | – | Sell |
-300,000
| Closed | -$22.4M | – | 310 |
|
2021
Q1 | $22.4M | Sell |
300,000
-300,000
| -50% | -$22.4M | 0.11% | 101 |
|
2020
Q4 | $102M | Hold |
600,000
| – | – | 0.62% | 44 |
|
2020
Q3 | $84.3M | Buy |
600,000
+75,000
| +14% | +$10.5M | 0.58% | 45 |
|
2020
Q2 | $84.2M | Buy |
525,000
+175,000
| +50% | +$28.1M | 0.67% | 43 |
|
2020
Q1 | $34.2M | Buy |
+350,000
| New | +$34.2M | 0.29% | 51 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 121 |
|
2019
Q3 | – | Sell |
-500,000
| Closed | -$76M | – | 111 |
|
2019
Q2 | $76M | Sell |
500,000
-150,000
| -23% | -$22.8M | 0.49% | 46 |
|
2019
Q1 | $77.5M | Buy |
650,000
+10,000
| +2% | +$1.19M | 0.58% | 42 |
|
2018
Q4 | $69.8M | Buy |
640,000
+445,000
| +228% | +$48.6M | 0.51% | 38 |
|
2018
Q3 | $31.5M | Buy |
+195,000
| New | +$31.5M | 0.19% | 55 |
|